TELO
Telomir Pharmaceuticals, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$45.73M
P/E Ratio
—
EPS
$-0.33
Beta
-0.73
52W High
$3.10
52W Low
$1.05
50-Day MA
$1.25
200-Day MA
$1.42
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -317.60% |
| Return on Assets | -152.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.17 |
| Price-to-Book | 7.38 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $34.38M |
| Float | $19.03M |
| % Insiders | 48.93% |
| % Institutions | 6.65% |
Historical Volatility
HV 10-Day
95.54%
HV 20-Day
81.95%
HV 30-Day
75.94%
HV 60-Day
64.79%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/9/2026